Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
AstraZeneca
Deloitte
Daiichi Sankyo
McKesson
Queensland Health
Dow
Boehringer Ingelheim
Moodys
Express Scripts

Generated: October 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090395

« Back to Dashboard
NDA 090395 describes OFLOXACIN, which is a drug marketed by Akorn, Apotex Inc, Hi Tech Pharma, Ranbaxy Labs Ltd, Bausch And Lomb, Sandoz Inc, Alvogen, Sandoz, Cadila Pharms Ltd, Fdc Ltd, Bedford, Teva, Altaire Pharms Inc, Larken Labs, and Dr Reddys Labs Ltd, and is included in twenty NDAs. It is available from thirty-three suppliers. Additional details are available on the OFLOXACIN profile page.

The generic ingredient in OFLOXACIN is ofloxacin. There are seventy-one drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the ofloxacin profile page.

Summary for NDA: 090395

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 090395

Ingredient-typeQuinolones

Suppliers and Packaging for NDA: 090395

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OFLOXACIN
ofloxacin
SOLUTION/DROPS;OTIC 090395 ANDA PharmaForce, Inc. 40042-049 40042-049-05 1 BOTTLE, PLASTIC in 1 CARTON (40042-049-05) > 5 mL in 1 BOTTLE, PLASTIC
OFLOXACIN
ofloxacin
SOLUTION/DROPS;OTIC 090395 ANDA PharmaForce, Inc. 40042-049 40042-049-10 1 BOTTLE, PLASTIC in 1 CARTON (40042-049-10) > 10 mL in 1 BOTTLE, PLASTIC

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OTICStrength0.3%
Approval Date:Aug 11, 2009TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Merck
McKinsey
Novartis
US Army
Covington
Teva
Chinese Patent Office
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot